特定于Gαs的结构元素减弱了与G蛋白信号传导 (RGS) 蛋白调节器的相互作用
Sabreen Higazy-Mreih1, Meirav Avital-Shacham1, Christian LeGouill2
1Department of Human Biology, Faculty of Natural Science, University of Haifa, Israel.
The FEBS journal
|May 28, 2025
概括
调节器的G蛋白信号传递 (RGS) 蛋白质通常使Gα子单元失活,但Gαs是一个例外. 在GTPase域中的三个特定的Gαs残留物阻止了RGS相互作用,解释了这种分歧.
科学领域:
- 分子生物学分子生物学
- 生物化学 生物化学
- 结构生物学是结构生物学.
背景情况:
- 异构G蛋白 (αβγ) 作为由G蛋白结合受体 (GPCRs) 调节的分子开关.
- 调节器的G蛋白信号传递 (RGS) 蛋白质使Gα子单元失活,通过加速GTP水解来控制信号的持续时间.
- Gαs是独一无二的,因为它与已知的RGS蛋白质没有相互作用,这一现象尚未完全理解.
研究的目的:
- 阐明导致Gαs和RGS蛋白之间缺乏相互作用的分子机制.
- 为了识别特定的结构特征或残留物,负责Gαs与RGS蛋白的不同相互作用概况.
主要方法:
- 实验和建模的Gαs结构的比较结构分析.
- 功能生物化学测定,包括突变发生和GTPase激活蛋白 (GAP) 活性测量.
- 在模型中预测结构相互作用.
主要成果:
- 与其他Gα子单元相比,Gαs在其螺旋和GTPase域中具有独特的结构元素.
- 建模表明,由于螺旋域插入或GTPase域残留,可能会对RGS结合产生干扰.
- 突变酶在Gαs GTPase域中确定了三种特定的残留物,这些残留物是必要的和足够的,以防止RGS介导的失活.
- 将这些Gαs残留物替换为Gαi1的残留物使Gαs易受RGS无活化.
结论:
- Gαs GTPase域的独特结构,特别是三个残留物,直接防止RGS蛋白质的不活化.
- 这些发现揭示了RGS相互作用中G蛋白特异性的机制基础.
- 了解这种分歧可以了解G蛋白信号通路的调节.
相关概念视频
Activation and Inactivation of G Proteins
11.1K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.1K
Amplifying Signals via Enzymatic Cascade
17.5K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.5K
Assembly of Signaling Complexes
6.5K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
6.5K
GPCR Desensitization
8.0K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.0K
GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
Transducer Mechanism: G Protein–Coupled Receptors
4.0K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
4.0K


